![]() | Only 14 pages are availabe for public view |
Abstract Background: Cardiovascular dysfunction could be a major underlying mechanism of weaning failure. BNP; a marker for cardiovascular dysfunction, may predict the outcome of weaning from MV. Objective: To evaluate the role of BNP levels measured during start of MV& SBT as a predictive value for weaning outcome. Method: Thirty patients difficult weaning from MV who underwent an SBT. .Echocardiography was done at start of MV and sampling of N-terminal pro BNP at start of MV and at SBT to determine the predictive value of BNP. Results: Patients throughout the SBT trial showed increase of RSBI (108.1±9.8 vs.40.6±6.9 breath/min/l p<0.05) & P/F І was higher than P/FІІ (206.3±38 vs. 111.4±17.5, p≤ 0.05). and ECHO data showed all patients had diastolic dysfunction and grade ІІ represented 70% and grade І represented30%, there was increase in N -terminal pro BNP at SBT (15275±6667.7vs 1599.7±1448.7 ng/L p <0.05). By using ROC analysis we found that at a cutoff point of 1765 ng/L of N-terminal pro BNP at start of MV we can predict weaning failure and mortality with sensitivity 78.3% & specificity 57.1% And at a cutoff point18500 ng/L of N-terminal pro BNP at SBT we can predict weaning failure and mortality with sensitivity 87% & specificity 57.1%.The mean of N-terminal pro BNP in non-survivor at start of MV was 2764.3 ng/L with p-value<0.05 and 20178.6 ng/L with p- value<0.05 at SBT and we found the mean among survivor at start of MV was 1245.2 ng/L with p-value <0.05 and the mean was13782.6ng/L with p-value <0.05 at SBT. Conclusions: N-terminal pro BNP and left ventricular diastolic dysfunction at start of MV can be used to predict weaning failure as well as mortality in MV patients due to cardiac cause. |